This inventor holds 24 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in CNS Disorders Treatment. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Karo Bio Ab. Active years: 2000-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chicago, IL (US) (2003)
- Evanston, IL (US) (2000 - 2011)
- Standford, CA (US) (2013)
- Stanford, CA (US) (2010 - 2016)
Company Filing History:
15 out of 4,190 
6 out of 827 
2 out of 34 
Years Active: 2000-2016
Areas of Expertise:
Title: Innovations and Contributions of James T. Link
Introduction
James T. Link is a notable inventor based in Stanford, CA, with an impressive portfolio of 24 patents. His work primarily focuses on the treatment of central nervous system disorders, showcasing his commitment to advancing medical science and improving patient care.
Latest Patents
Among Link's latest contributions is a patent that describes a method for treating patients suffering from various central nervous system disorders, including those associated with diabetes, aging, and neurodegeneration. This innovative method involves administering an effective amount of a selective inhibitor of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme activity, aiming to benefit individuals suffering from conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer’s disease, mild cognitive impairment, and schizophrenia, among others. Additionally, he holds a patent related to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme, which are used in the treatment of numerous conditions, including type 2 diabetes, insulin resistance, and metabolic syndrome.
Career Highlights
James T. Link has had a distinguished career, contributing significantly to the fields of medical research and pharmaceutical development. He has worked with renowned organizations, including Abbott Laboratories Corporation and AbbVie Inc., where he further developed his expertise and innovations that have the potential to transform patient treatment options.
Collaborations
Throughout his career, Link has collaborated with various talented professionals, including Bryan K. Sorensen and Jyoti R. Patel. These partnerships have fostered the exchange of ideas and the development of new therapeutic approaches, underlining the collaborative nature of innovation in the medical field.
Conclusion
James T. Link's extensive work in developing treatments for central nervous system disorders positions him as a significant figure in medical innovation. His dedication to research and his impressive collection of patents reflect his contribution to improving healthcare outcomes. As he continues to advance his research, the impact of his work will likely resonate in both the medical community and the lives of patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile